317 related articles for article (PubMed ID: 17678726)
1. High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer.
Cozar JM; Romero JM; Aptsiauri N; Vazquez F; Vilchez JR; Tallada M; Garrido F; Ruiz-Cabello F
Hum Immunol; 2007 Aug; 68(8):698-704. PubMed ID: 17678726
[TBL] [Abstract][Full Text] [Related]
2. Increased frequency of the CTLA-4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls.
Pavlova A; Diaz-Lacava A; Zeitler H; Satoguina J; Niemann B; Krause M; Scharrer I; Hoerauf A; Wienker T; Oldenburg J
Haemophilia; 2008 Mar; 14(2):355-60. PubMed ID: 18081831
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic T-lymphocyte antigen-4-CT60 polymorphism in rheumatoid arthritis.
Orozco G; Torres B; Núñez-Roldán A; González-Escribano MF; Martín J
Tissue Antigens; 2004 Dec; 64(6):667-70. PubMed ID: 15546339
[TBL] [Abstract][Full Text] [Related]
4. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
Ulker M; Yazisiz V; Sallakci N; Avci AB; Sanlioglu S; Yegin O; Terzioglu E
Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
[TBL] [Abstract][Full Text] [Related]
5. [Relationship of CTLA-4 exon 1 A49-->G polymorphism with sCTLA-4 and Th1/Th2 bias in idiopathic dilated cardiomyopathy].
Liu W; Li WM; Gao C; Wang XR; Li DM; Sun NL
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3221-4. PubMed ID: 16405845
[TBL] [Abstract][Full Text] [Related]
6. 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease.
Bicek A; Zaletel K; Gaberscek S; Pirnat E; Krhin B; Stopar TG; Hojker S
Hum Immunol; 2009 Oct; 70(10):820-4. PubMed ID: 19559744
[TBL] [Abstract][Full Text] [Related]
7. CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndrome.
Gottenberg JE; Loiseau P; Azarian M; Chen C; Cagnard N; Hachulla E; Puechal X; Sibilia J; Charron D; Mariette X; Miceli-Richard C
Arthritis Res Ther; 2007; 9(2):R24. PubMed ID: 17341301
[TBL] [Abstract][Full Text] [Related]
8. CTLA-4 gene 49A/G polymorphism in Turkish patients with Behçet's disease.
Sallakci N; Bacanli A; Coskun M; Yavuzer U; Alpsoy E; Yegin O
Clin Exp Dermatol; 2005 Sep; 30(5):546-50. PubMed ID: 16045690
[TBL] [Abstract][Full Text] [Related]
9. Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population.
Pawlak E; Karabon L; Wlodarska-Polinska I; Jedynak A; Jonkisz A; Tomkiewicz A; Kornafel J; Stepien M; Ignatowicz A; Lebioda A; Dobosz T; Frydecka I
Hum Immunol; 2010 Feb; 71(2):195-200. PubMed ID: 19913589
[TBL] [Abstract][Full Text] [Related]
10. CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women.
Su TH; Chang TY; Lee YJ; Chen CK; Liu HF; Chu CC; Lin M; Wang PT; Huang WC; Chen TC; Yang YC
Carcinogenesis; 2007 Jun; 28(6):1237-40. PubMed ID: 17341658
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.
Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T
Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089
[TBL] [Abstract][Full Text] [Related]
12. A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma.
Romero JM; Sáenz-López P; Cózar JM; Carretero R; Canton J; Vazquez F; Concha A; Tallada M; Garrido F; Ruiz-Cabello F
Hum Immunol; 2009 Jan; 70(1):60-4. PubMed ID: 19027043
[TBL] [Abstract][Full Text] [Related]
13. Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients.
Sáenz-López P; Carretero R; Vazquez F; Martin J; Sánchez E; Tallada M; Garrido F; Cózar JM; Ruiz-Cabello F
Hum Immunol; 2010 Mar; 71(3):309-13. PubMed ID: 19961892
[TBL] [Abstract][Full Text] [Related]
14. Association of a CTLA-4 3' untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population.
Ban Y; Tozaki T; Taniyama M; Tomita M; Ban Y
Autoimmunity; 2005 Mar; 38(2):151-3. PubMed ID: 16040335
[TBL] [Abstract][Full Text] [Related]
15. Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis.
Barton A; Jury F; Eyre S; Bowes J; Hinks A; Ward D; Worthington J
Arthritis Rheum; 2004 Mar; 50(3):748-52. PubMed ID: 15022315
[TBL] [Abstract][Full Text] [Related]
16. Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjögren's syndrome.
Downie-Doyle S; Bayat N; Rischmueller M; Lester S
Arthritis Rheum; 2006 Aug; 54(8):2434-40. PubMed ID: 16869018
[TBL] [Abstract][Full Text] [Related]
17. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
[TBL] [Abstract][Full Text] [Related]
18. CTLA4/CT60 polymorphism is not relevant in susceptibility to autoimmune inflammatory intestinal disorders.
Rueda B; Zhernakova A; López-Nevot MA; Gomez-Garcia M; Ortega E; Piñero A; Correro F; Brieva JA; Nieto A; Koeleman BP; Martín J
Hum Immunol; 2005 Mar; 66(3):321-5. PubMed ID: 15784471
[TBL] [Abstract][Full Text] [Related]
19. Analysis of CD28 and CTLA-4 gene polymorphisms in Turkish patients with Behcet's disease.
Gunesacar R; Erken E; Bozkurt B; Ozer HT; Dinkci S; Erken EG; Ozbalkan Z
Int J Immunogenet; 2007 Feb; 34(1):45-9. PubMed ID: 17284227
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T lymphocyte antigen-4 gene in breast cancer.
Ghaderi A; Yeganeh F; Kalantari T; Talei AR; Pezeshki AM; Doroudchi M; Dehaghani AS
Breast Cancer Res Treat; 2004 Jul; 86(1):1-7. PubMed ID: 15218356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
